IGC Pharma, Inc. financial data

Symbol
IGC on NYSE
Industry
Pharmaceutical Preparations
Location
10224 Falls Road, Potomac, MD
State of incorporation
MD
Fiscal year end
March 31
Former names
India Globalization Capital, Inc. (to 3/21/2023)
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 167 % -53.8%
Quick Ratio 67.8 % -56.5%
Debt-to-equity 33.2 % +126%
Return On Assets -119 % -91.7%
Operating Margin -788 % +2.99%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 77.4M shares +21.5%
Common Stock, Shares, Outstanding 76.6M shares +20.3%
Entity Public Float 20.9M USD +0.34%
Weighted Average Number of Shares Outstanding, Basic 76M shares +40%
Weighted Average Number of Shares Outstanding, Diluted 76M shares +40%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.18M USD -11.9%
Cost of Revenue 518K USD -30.8%
Research and Development Expense 3.56M USD +7.54%
Operating Income (Loss) -9.32M USD +14.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.6M USD -16.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -12.6M USD -16.3%
Earnings Per Share, Basic -0.02 USD/shares +60%
Earnings Per Share, Diluted -0.02 USD/shares +60%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.55M USD -48.9%
Marketable Securities, Current 154K USD
Accounts Receivable, after Allowance for Credit Loss, Current 44K USD -67.9%
Inventory, Net 1.51M USD -42.7%
Other Assets, Current 198K USD +38.5%
Assets, Current 4.25M USD -30.5%
Other Long-term Investments 0 USD -100%
Property, Plant and Equipment, Net 3.47M USD -56.4%
Operating Lease, Right-of-Use Asset 161K USD -38.8%
Intangible Assets, Net (Excluding Goodwill) 1.8M USD +52.7%
Other Assets, Noncurrent 687K USD -31.2%
Assets 10.4M USD -37.2%
Accounts Payable, Current 768K USD +39.9%
Employee-related Liabilities, Current 1.03M USD +38.1%
Accrued Liabilities, Current 2.03M USD +30.6%
Liabilities, Current 2.8M USD +33%
Operating Lease, Liability, Noncurrent 35K USD -76%
Other Liabilities, Noncurrent 20K USD +17.6%
Liabilities 2.99M USD +24.3%
Common Stocks, Including Additional Paid in Capital 129M USD +4.76%
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.44M USD +0.06%
Retained Earnings (Accumulated Deficit) -118M USD -11.9%
Stockholders' Equity Attributable to Parent 7.38M USD -47.7%
Liabilities and Equity 10.4M USD -37.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.75M USD -19.3%
Net Cash Provided by (Used in) Financing Activities 2.51M USD
Net Cash Provided by (Used in) Investing Activities -131K USD -2520%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 76.6M shares +20.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 626K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.55M USD -48.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 15M USD +10.3%
Deferred Tax Assets, Gross 15M USD +10.3%
Operating Lease, Liability 208K USD -38.8%
Depreciation 573K USD +48.4%
Payments to Acquire Property, Plant, and Equipment 38K USD +90%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.6M USD -15.5%
Lessee, Operating Lease, Liability, to be Paid 340K USD -26.7%
Property, Plant and Equipment, Gross 6.06M USD -40.2%
Operating Lease, Liability, Current 134K USD +3.08%
Lessee, Operating Lease, Liability, to be Paid, Year Two 87K USD -34.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 132K USD -12.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11K USD -64.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD -100%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 0 USD
Operating Lease, Payments 26K USD -3.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 78K USD +13%
Depreciation, Depletion and Amortization 162K USD +4.52%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 402K USD +12.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%